← SynDRA
FLUTICASONE FUROATE
SynDRA canonical compound SYN0018472 — structure-anchored drug synonym record
| Clinical phase | Launched |
| Approval status | Approved · Rx |
| Primary target(s) | NR3C1 | NR3C2 | PGR |
| Mechanism of action | glucocorticoid receptor agonist |
| Indication | asthma |
| Disease area | pulmonary |
All known targets
Mechanisms of action (all sources)
Drug classes
- Corticosteroid Hormone Receptor Agonists
- Corticosteroid
- Anti-Allergic Agents
- Anti-Asthmatic Agents
- Anti-Inflammatory Agents
- Bronchodilator Agents
- Dermatologic Agents
- Peripheral Nervous System Agents
- Respiratory System Agents
ATC classes
- R01A · DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE
- R03B · OTHER DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES, INHALANTS
- CORTICOSTEROIDS, PLAIN
- ADRENERGICS, INHALANTS
Cross-references
Synonyms
- avamys
- veramyst
- Furoate de fluticasone
- Furoato de fluticasona
- Allermist
- Ennhale
- Furamist
- GSK 685 698
- GSK-685968
- GSK685968
- GW-685698X
- GW685698X
- Alisade
- Arnuity ellipta
- Avamys
- Flonase sensimist allergy relief
- Fluticasone furoate component of arnuity ellipta
- Fluticasone furoate component of breo ellipta
- Fluticasone furoate component of trelegy ellipta
- Relvar ellipta
- Trelegy ellipta
- Veramyst
- GW6
- GW-685698
- Veramyst (TN)
- Fluticasone furoate (JAN/USAN/INN)
- (6alpha,11beta,16alpha,17alpha)-6,9-Difluoro-17-(((fluoromethyl)thio)carbonyl)-11-hydroxy-16-methyl-3-oxoandrosta-1,4-dien-17-yl-2-furancarboxylate
- 6alpha,9-Difluoro-17-(((fluoromethyl)sulfanyl)carbonyl)-11beta-hydroxy-16alpha-methyl-3-oxoandrosta-1,4-dien-17alpha-yl furan-2-carboxylate
- BREO ELLIPTA COMPONENT FLUTICASONE FUROATE
- ARNUITY ELLIPTA COMPONENT FLUTICASONE FUROATE
- TRELEGY ELLIPTA COMPONENT FLUTICASONE FUROATE
- GW 685698X
- JS86977WNV
- Arnuity Ellipta
- Flonase Sensimist
- furoate de fluticasone
- furoato de fluticasona
Look up FLUTICASONE FUROATE in the interactive SynDRA portal →